- Home
- CPRX vs BATRA Comparison
CPRX vs BATRA Comparison
Compare CPRX & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- BATRA
- Stock Information
- Founded
- CPRX 2002
- BATRA 1991
- Country
- CPRX United States
- BATRA United States
- Employees
- CPRX N/A
- BATRA N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- BATRA Broadcasting
- Sector
- CPRX Health Care
- BATRA Industrials
- Exchange
- CPRX Nasdaq
- BATRA Nasdaq
- Market Cap
- CPRX 2.9B
- BATRA 2.6B
- IPO Year
- CPRX 2006
- BATRA N/A
- Fundamental
- Price
- CPRX $21.03
- BATRA $49.59
- Analyst Decision
- CPRX Strong Buy
- BATRA Strong Buy
- Analyst Count
- CPRX 6
- BATRA 3
- Target Price
- CPRX $32.83
- BATRA $58.00
- AVG Volume (30 Days)
- CPRX 1.4M
- BATRA 77.9K
- Earning Date
- CPRX 08-06-2025
- BATRA 08-07-2025
- Dividend Yield
- CPRX N/A
- BATRA N/A
- EPS Growth
- CPRX 178.13
- BATRA N/A
- EPS
- CPRX 1.57
- BATRA N/A
- Revenue
- CPRX $534,645,999.00
- BATRA $672,879,000.00
- Revenue This Year
- CPRX $16.37
- BATRA $8.81
- Revenue Next Year
- CPRX $8.80
- BATRA $5.01
- P/E Ratio
- CPRX $13.41
- BATRA N/A
- Revenue Growth
- CPRX 29.97
- BATRA 4.04
- 52 Week Low
- CPRX $15.34
- BATRA $38.67
- 52 Week High
- CPRX $26.58
- BATRA $50.50
- Technical
- Relative Strength Index (RSI)
- CPRX 38.08
- BATRA 65.34
- Support Level
- CPRX $20.60
- BATRA $48.80
- Resistance Level
- CPRX $22.10
- BATRA $50.50
- Average True Range (ATR)
- CPRX 0.68
- BATRA 0.96
- MACD
- CPRX 0.05
- BATRA -0.08
- Stochastic Oscillator
- CPRX 28.67
- BATRA 87.60
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BATRA Atlanta Braves Holdings Inc. Series A
Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.